During the corresponding time, Tandem Diabetes Care Inc recorded a revenue increase by 5.77 % year on year, sequentially revenue grew by 3.15 %. While revenue at the Tandem Diabetes Care Inc 's corporate clients
Tandem Diabetes Care Inc's Comment on Sales, Marketing and Customers
The company provides diabetes therapy management data for individuals with insulin-dependent diabetes through platforms such as Tandem Source and the Sugarmate mobile app. Tandem Source is a web-based data management platform available in most global markets served, integrating features from legacy offerings and enabling automatic data transfers from insulin pumps. Sugarmate assists users in logging glucose and health data and delivers alerts to users and their caregivers. The company targets multiple market segments based on clinical needs, preferences, and affordability, offering flexible insulin delivery systems. Its products are available in over 25 countries. In the United States and Canada, sales and support are conducted directly, with partnerships with independent distributors handling order fulfillment. Internationally, distributors have historically managed sales, support, and order fulfillment; however, the company plans to transition to direct sales and support in markets including the United Kingdom, Austria, and Switzerland beginning in 2026. Independent distributors in the U.S. and Canada play a significant role in order fulfillment but maintain minimal inventory. Market segments include individuals with insulin-dependent diabetes, their caregivers, and healthcare providers.
Tandem Diabetes Secures FDA Approval for Mobile App: A New Era in Insulin Delivery Technology In a significant advancement for diabetes management, Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a pioneering company in the field of insulin delivery and diabetes technology, has announced the U.S. Food and Drug Administration s (FDA) clearance of the Android version of its Tandem Mobi mobile app. This development marks a critical step forward in making diabetes management more accessible and effective for millions of individuals relying on insulin therapy. The Tandem Mobi System: A Game Changer for Insulin DeliveryThe Tandem Mobi system is hailed as the world’s smallest automated insulin delivery system. Its sle...
In the ever-evolving landscape of diabetes management, Tandem Diabetes Care, Inc. (NASDAQ: TNDM) continues to forge forward with transformative innovations that are set to redefine patient experiences and outcomes. Based in San Diego, Tandem Diabetes Care is a leader in insulin delivery and diabetes technology, with groundbreaking advancements that cater to the nuanced needs of individuals living with diabetes. A New Era of Personalized Diabetes ManagementThe latest announcement from Tandem Diabetes Care reveals a significant milestone: the integration of the t:slim X2 insulin pump with Abbott s FreeStyle Libre 3 Plus continuous glucose monitoring (CGM) sensor in the United States. This integration exemplifi...
In a significant advancement for diabetes management, Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) have announced that the t:slim X2 insulin pump integrated with the latest Dexcom G7 Continuous Glucose Monitoring (CGM) system has received authorization for sale from Health Canada. This innovative integration emphasizes a commitment to enhancing the efficiency and effectiveness of diabetes care for patients.The t:slim X2, equipped with Control-IQ technology, stands as Canada’s leading Automated Insulin Delivery (AID) system, known for its ability to adjust insulin delivery based on continuous glucose monitoring. The new software update enables users to seamlessly integrate the D...
Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM: A Breakthrough in Diabetes Management SAN DIEGO - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) today announced a significant advancement in diabetes management, unveiling the full compatibility of the Tandem Mobi insulin pump with the Dexcom G7 Continuous Glucose Monitoring (CGM) System. This announcement underscores Tandem Mobi s status as an innovative leader in automated insulin delivery (AID) systems, having launched earlier this year in the United States. A Technological Milestone Tandem Mobi, celebrated as the world’s smallest and most durable AID system, already supports the Dexcom G6 CGM. The addition of Dexc...
Tandem Diabetes Care Inc’s Comment on Sales, Marketing and Customers
The company provides diabetes therapy management data for individuals with insulin-dependent diabetes through platforms such as Tandem Source and the Sugarmate mobile app. Tandem Source is a web-based data management platform available in most global markets served, integrating features from legacy offerings and enabling automatic data transfers from insulin pumps. Sugarmate assists users in logging glucose and health data and delivers alerts to users and their caregivers. The company targets multiple market segments based on clinical needs, preferences, and affordability, offering flexible insulin delivery systems. Its products are available in over 25 countries. In the United States and Canada, sales and support are conducted directly, with partnerships with independent distributors handling order fulfillment. Internationally, distributors have historically managed sales, support, and order fulfillment; however, the company plans to transition to direct sales and support in markets including the United Kingdom, Austria, and Switzerland beginning in 2026. Independent distributors in the U.S. and Canada play a significant role in order fulfillment but maintain minimal inventory. Market segments include individuals with insulin-dependent diabetes, their caregivers, and healthcare providers.
Sources:
Tandem Diabetes Care Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Tandem Diabetes Care Inc’s corporate clients.
For your research, we’ve provided 9 tables on Tandem Diabetes Care Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
133.62 %